Clinical Trial Update: Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SCM-AGH in acute pancreatitis reports safety and efficacy data across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• SCM-AGH

Snippet

Sponsor: SCM Lifescience Co., LTD. | Conditions: Pancreatitis, Acute | Phase 1, Phase 2 | Status: COMPLETED